Tigecycline: A single antibiotic for polymicrobial infections

Pediatric Infectious Disease Journal

Volumn 26, Issue 1, 2007, Pages 77-78

  Pankey, George A ^a   Steele, Russell W ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; AZTREONAM; CILASTATIN PLUS IMIPENEM; IMIPENEM; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; RIFAMPICIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN; WARFARIN;

ABDOMINAL INFECTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBACTERIAL ACTIVITY; APPENDICITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL STRAIN; BLOOD PRESSURE MEASUREMENT; BONE DISCOLORATION; BONE DISEASE; BRAIN PSEUDOTUMOR; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG INHIBITION; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY MONITORING; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOPROTHROMBINEMIA; IN VITRO STUDY; INFECTION COMPLICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIXED INFECTION; NAUSEA; PANCREATITIS; PARESTHESIA; PHOTOSENSITIVITY; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PRURITUS; SHORT SURVEY; SIDE EFFECT; SKIN INFECTION; THERAPY EFFECT; TOOTH DISCOLORATION; TREATMENT INDICATION; TREATMENT RESPONSE; VOMITING;

EID: 33845976709     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000253038.78188.26     Document Type: Article

References (11)

1. Pankey GA. Tigecycline. J Antimicrob Chemother. 2005;56:470-480.
2. Stein GE, et al. Tigecycline: A critical analysis. Clin Infect Dis. 2006;43:518-524.
3. Lefort A, et al. Activity and diffusion of tigecycline . . . Antimicrob Agents Chemother. 2003;47:216-222.
4. Biedenbach DJ, et al. In vitro antimicrobial activity of GAR-936 . . . Diagn Microbiol Infect Dis. 2001;40:173-177.
5. Chopra I. Glycylcyclines: Third-generation tetracycline antibiotics. Curr Opin Pharmacol. 2001;1:464-469.
6. Mikels SM, et al. In vitro activities of GAR-936 . . . In: Programs and Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington, DC: American Society of Microbiology; 1999;26:Abstract 414.
7. Projan SJ. Preclinical pharmacology of GAR-936 . . . Pharmacotherapy. 2000;20:219S-223S.
8. Dartois N, et al. Tigecycline vs imipenem/cilastatin . . . In: Programs and Abstracts of the Forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC. Washington, DC: American Society of Microbiology; 2004;12:Abstract LB-992c.
9. Stein GE. Safety of newer parenteral antibiotics. Clin Infect Dis. 2005;41(suppl 5):S293-302.
10. Postier RG, et al. Results of a multicenter, randomized . . . Clin Ther. 2004;26:704-714.
11. Zhanel GG, et al. The glycylcyclines: A comparative review with the tetracyclines. Drugs. 2004;64:63-88.